Zarrabi, A.; Perrin, D.; Kavoosi, M.; Sommer, M.; Sezen, S.; Mehrbod, P.; Bhushan, B.; Machaj, F.; Rosik, J.; Kawalec, P.; Afifi, S.; Bolandi, S.M.; Koleini, P.; Taheri, M.; Madrakian, T.; Łos, M.J.; Lindsey, B.; Cakir, N.; Zarepour, A.; Hushmandi, K.; Fallah, A.; Koc, B.; Khosravi, A.; Ahmadi, M.; Logue, S.; Orive, G.; Pecic, S.; Gordon, J.W.; Ghavami, S. Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies. Cancers2023, 15, 5269.
Zarrabi, A.; Perrin, D.; Kavoosi, M.; Sommer, M.; Sezen, S.; Mehrbod, P.; Bhushan, B.; Machaj, F.; Rosik, J.; Kawalec, P.; Afifi, S.; Bolandi, S.M.; Koleini, P.; Taheri, M.; Madrakian, T.; Łos, M.J.; Lindsey, B.; Cakir, N.; Zarepour, A.; Hushmandi, K.; Fallah, A.; Koc, B.; Khosravi, A.; Ahmadi, M.; Logue, S.; Orive, G.; Pecic, S.; Gordon, J.W.; Ghavami, S. Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies. Cancers 2023, 15, 5269.
Zarrabi, A.; Perrin, D.; Kavoosi, M.; Sommer, M.; Sezen, S.; Mehrbod, P.; Bhushan, B.; Machaj, F.; Rosik, J.; Kawalec, P.; Afifi, S.; Bolandi, S.M.; Koleini, P.; Taheri, M.; Madrakian, T.; Łos, M.J.; Lindsey, B.; Cakir, N.; Zarepour, A.; Hushmandi, K.; Fallah, A.; Koc, B.; Khosravi, A.; Ahmadi, M.; Logue, S.; Orive, G.; Pecic, S.; Gordon, J.W.; Ghavami, S. Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies. Cancers2023, 15, 5269.
Zarrabi, A.; Perrin, D.; Kavoosi, M.; Sommer, M.; Sezen, S.; Mehrbod, P.; Bhushan, B.; Machaj, F.; Rosik, J.; Kawalec, P.; Afifi, S.; Bolandi, S.M.; Koleini, P.; Taheri, M.; Madrakian, T.; Łos, M.J.; Lindsey, B.; Cakir, N.; Zarepour, A.; Hushmandi, K.; Fallah, A.; Koc, B.; Khosravi, A.; Ahmadi, M.; Logue, S.; Orive, G.; Pecic, S.; Gordon, J.W.; Ghavami, S. Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies. Cancers 2023, 15, 5269.
Abstract
Rhabdomyosarcoma is a rare cancer arising in skeletal muscle that typically impacts children and young adults. It is a worldwide challenge in child health as treatment outcomes for metastatic and recurrent disease still pose a major concern for both basic and clinical scientists. The treatment strategies for rhabdomyosarcoma include multi-agent chemotherapies after surgical resection with or without ionization radiotherapy. In this comprehensive review, we first provide a detailed clinical understanding of rhabdomyosarcoma including its classification and subtypes, diagnosis, and treatment strategies. Later we focus on chemotherapy strategies for this childhood sarcoma and discuss the impact of three mechanisms that are involved in chemotherapy response including apoptosis, macro-autophagy, and the unfolded protein response. Finally, we discuss in vivo mouse and zebrafish models, and in vitro 3-dimensional bioengineering models of Rhabdomyosarcoma to screen future therapeutic approaches and promote muscle regeneration.
Keywords
Alveolar Rhabdomyosarcoma; Apoptosis; Autophagy; Unfolded Protein Response; Bioengineering; Tumor Stiffness
Subject
Biology and Life Sciences, Life Sciences
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.